Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic
- PMID: 8319368
- DOI: 10.1111/j.1365-2265.1993.tb00516.x
Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic
Abstract
Background: The pathogenesis of thyroid-associated ophthalmopathy is thought to be autoimmune, although environmental and genetic factors are also considered to be important. As the morbidity of thyroid-associated ophthalmopathy is considerable and treatment often unsatisfactory, there a need to identify possible predisposing factors.
Objective: The study was undertaken in order to ascertain the relationship between age, gender and severity of thyroid-associated ophthalmopathy.
Patients: One hundred and one consecutive patients with thyroid-associated ophthalmopathy who presented over a period of 5 years to a combined thyroid-eye clinic.
Methods: Patients were assessed by grading their inflammatory signs and degree of diplopia, and by measurement of exophthalmos, palpebral aperture, differential intraocular pressure, and visual acuity. On the basis of the above an ophthalmopathy index was devised to grade the overall severity of eye disease.
Results: The mean age was 49.2 years (SD 13.4), the female-to-male ratio was 4.05, and mean ophthalmopathy index 6.49 (SD 3.3). Optic nerve compression was present in 9.9% of patients. There was a positive relationship between age and ophthalmopathy index (P < 0.001); after correcting for age, males had an average ophthalmopathy index 41% greater than that of females.
Conclusion: There is an association between severity of thyroid-associated ophthalmopathy and (i) advancing age and (ii) female-to-male ratio, which has not been previously described. Patients over the age of 60 (particularly males) with Graves' disease appear to be at risk of developing severe eye disease.
Similar articles
-
Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease.J Endocrinol Invest. 1988 Sep;11(8):615-9. doi: 10.1007/BF03350193. J Endocrinol Invest. 1988. PMID: 2907524
-
Correlation of orbital muscle changes evaluated by magnetic resonance imaging and thyroid-stimulating antibody in patients with Graves' ophthalmopathy.Acta Endocrinol (Copenh). 1993 Sep;129(3):213-9. doi: 10.1530/acta.0.1290213. Acta Endocrinol (Copenh). 1993. PMID: 8105634
-
Azathioprine in the treatment of thyroid-associated ophthalmopathy.Acta Endocrinol (Copenh). 1990 Jan;122(1):8-12. doi: 10.1530/acta.0.1220008. Acta Endocrinol (Copenh). 1990. PMID: 2305608
-
Epidemiology and prevention of Graves' ophthalmopathy.Thyroid. 2002 Oct;12(10):855-60. doi: 10.1089/105072502761016476. Thyroid. 2002. PMID: 12487767 Review.
-
Graves' ophthalmopathy.Can Med Assoc J. 1981 Apr 1;124(7):855-62, 866. Can Med Assoc J. 1981. PMID: 7011529 Free PMC article. Review.
Cited by
-
Radioiodine and thyroid-associated ophthalmopathy: from the myth to the reality.J Endocrinol Invest. 1999 Oct;22(9):705-7. doi: 10.1007/BF03343634. J Endocrinol Invest. 1999. PMID: 10595836 Review. No abstract available.
-
Altered peripapillary vessel density and nerve fiber layer thickness in thyroid-associated ophthalmopathy using optical coherence tomography angiography.Int Ophthalmol. 2022 Mar;42(3):855-862. doi: 10.1007/s10792-021-02051-1. Epub 2021 Oct 12. Int Ophthalmol. 2022. PMID: 34637060 Free PMC article.
-
Epidemiological Status of Thyroid Eye Disease in Central Iran.J Curr Ophthalmol. 2022 Apr 16;34(1):106-111. doi: 10.4103/joco.joco_223_21. eCollection 2022 Jan-Mar. J Curr Ophthalmol. 2022. PMID: 35620368 Free PMC article.
-
Prevalence and risk factors for thyroid eye disease among Korean dysthyroid patients.Korean J Ophthalmol. 2013 Dec;27(6):397-404. doi: 10.3341/kjo.2013.27.6.397. Epub 2013 Nov 15. Korean J Ophthalmol. 2013. PMID: 24311923 Free PMC article.
-
Risk factors for Graves' Orbitopathy in surgical patients-Results of a 10-year retrospective study with review of the literature.Endocrinol Diabetes Metab. 2020 Dec 4;4(1):e00210. doi: 10.1002/edm2.210. eCollection 2021 Jan. Endocrinol Diabetes Metab. 2020. PMID: 33532627 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials